LICENSE AGREEMENTLicense Agreement • October 16th, 2023 • 1427702 B.C. LTD • Pharmaceutical preparations • British Columbia
This Agreement (“Agreement”) is effective as of this 18th day of April 2022, (“Effective Date”) between FILAMENT HEALTH CORP. a British Columbia corporation, with offices at #210-4475 Wayburne Drive, Burnaby BC V5G4X4 (“Filament”) and PSYENCE BIOMED CORP, a corporation organized under the laws of British Columbia with an address at 200 Bay Street, Suite 2010 Toronto, Ontario, Canada M5J 2J1 (“Psyence”). Filament and Psyence may be referred to herein singularly as a “party” and collectively as the “parties”.
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • October 16th, 2023 • 1427702 B.C. LTD • Pharmaceutical preparations • Delaware
This License and Supply License and Supply Agreement (“Agreement”) is effective as of this 22 day of August 2023, (“Effective Date”) between FILAMENT HEALTH CORP. a British Columbia corporation, with offices at #210-4475 Wayburne Drive, Burnaby BC V5G4X4 (“Filament”) and RESET PHARMACEUTICALS, INC., a Delaware corporation having a principal place of business at 98 Cuttermilk Road, Suite 486, Great Neck, NY 11021, USA, (“Reset Pharma”). Filament and Reset Pharma may be referred to herein singularly as a “party” and collectively as the “parties”.
LICENCE AGREEMENTLicence Agreement • October 16th, 2023 • 1427702 B.C. LTD • Pharmaceutical preparations • British Columbia
This Agreement (“Agreement”) is effective as of this 27th day of June 2023, (“Effective Date”) between FILAMENT HEALTH CORP. a British Columbia corporation, with offices at #210-4475 Wayburne Drive, Burnaby BC V5G4X4 (“Filament”) and NeoLumina Bioscience Inc., a British Columbia corporation having a principal place of business at 7860 Venture St, Burnaby, BC, V5A 3A2 (“NeoLumina”). Filament and NeoLumina may be referred to herein singularly as a “Party” and collectively as the “Parties”.
